Dr
Jade
Cheng

Experience

Jade joined HGF’s Life Sciences group in February 2022 as a qualified UK and European patent attorney. She is also a representative before the Unified Patent Court.

Prior to becoming a patent attorney, Jade was a postdoctoral fellow at the Medical Research Council Laboratory of Molecular Biology (MRC LMB) in Cambridge. During her time as a researcher, she focussed on the blood–brain barrier and cellular mechanisms governing cell death and division.

Jade’s academic background gives her a first-hand understanding of the research process and the considerations involved in protecting scientific developments. This helps her work closely with inventors and clients from universities, research organisations and start-ups.

Jade specialises in protein- and nucleic acid-based therapeutics, including biologics and vaccines, as well as drug delivery technologies such as lipid nanoparticle systems. Her practice includes drafting and prosecuting patent applications, freedom-to-operate analyses, third-party observations, EPO oppositions and appeals, and advising on filing strategy. She coordinates patent prosecution across multiple jurisdictions in line with clients’ commercial objectives.

As a member of the HGF Venture team, Jade provides IP due diligence support to life sciences investors. She also advises early-stage companies on aligning their IP strategies with their business plans to strengthen their commercial position and maximise return on investment.

Jade is fluent in English and Cantonese.